Contact this trialFirst, we need to learn more about you.
Glucagon-like peptide-1 receptor agonist
Semaglutide 7.2 mg for Type 2 Diabetes
Recruiting1 awardPhase 3
Austin, Texas
This trial will compare weight loss & blood sugar control in those taking semaglutide vs. "dummy" medicine, with talks on healthy food & physical activity. Participants get semaglutide or "dummy" medicine, by chance, injected under skin with a thin needle. Dose of semaglutide gradually increases until reaching the target. Study lasts 1.5 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.